{"product_id":"buy-tesamorelin-canada","title":"Tesamorelin","description":"\u003ch2\u003e\u003cb\u003eBuy Tesamorelin Canada — Synthetic GHRH(1-44) Analog\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eBuy Tesamorelin in Canada as a research-grade GHRH analog for somatotropic axis, lean mass, and visceral adiposity research designs. Tesamorelin is a synthetic 44-amino-acid analog of growth-hormone-releasing hormone (GHRH), engineered with an N-terminal trans-3-hexenoic acid modification that confers resistance to DPP-IV cleavage. Developed by Montreal-based Theratechnologies and approved by the FDA in 2010 under the brand name Egrifta for visceral adiposity in HIV-associated lipodystrophy, Tesamorelin remains the only GHRH analog to receive regulatory approval. Each vial supplied by Emerald Peptides ships at ≥99% HPLC purity with mass-spec-verified identity, batch-specific certificate of analysis, and fast domestic Canadian shipping.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Lyophilized peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per vial:\u003c\/b\u003e 10 mg (filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified (per COA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eFormula \/ M.W.:\u003c\/b\u003e C₂₂₁H₃₆₆N₇₂O₆₇S \/ ~5135.9 Da\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCAS:\u003c\/b\u003e 218949-48-5\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes Tesamorelin a Unique Compound\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eTesamorelin was developed by Theratechnologies, Inc., a Montreal-based biotech, and remains the only GHRH analog to receive FDA approval — granted in 2010 for visceral adiposity reduction in HIV-associated lipodystrophy under the brand name Egrifta. That clinical track gives researchers a published human pharmacokinetic, pharmacodynamic, and safety dataset most research peptides cannot match.\u003c\/p\u003e\n\u003cp\u003eStructurally, Tesamorelin retains the full 44-amino-acid hGHRH sequence, distinguishing it from shorter GHRH fragments like sermorelin (GHRH 1-29). The trans-3-hexenoic acid moiety attached to the N-terminal tyrosine extends half-life by blocking DPP-IV cleavage at the Tyr¹-Ala² bond, the primary degradation site for native GHRH. Among Canadian research compounds with a documented clinical trail, Tesamorelin sits in a small group of GHRH-axis tools available for laboratory investigation.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eGH\/IGF-1 Axis Activation —\u003c\/b\u003e Tesamorelin elicits pulsatile GH secretion through GHRHR agonism, with downstream IGF-1 elevation observed across published preclinical and clinical pharmacodynamic studies — making it a reference tool for somatotropic-axis investigation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eLean Mass \u0026amp; Anabolic Research —\u003c\/b\u003e GH and IGF-1 elevation drive protein synthesis and skeletal muscle anabolism in published animal models, supporting Tesamorelin's use in research designs comparing GH-axis activation against alternative anabolic peptide mechanisms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eVisceral Adiposity —\u003c\/b\u003e Phase 3 clinical trials demonstrated dose-dependent reductions in visceral adipose tissue, mediated through GH-stimulated hormone-sensitive lipase activity. The dataset gives researchers a uniquely well-characterized human reference for GH-driven lipolysis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eLipid Metabolism \u0026amp; Cardiometabolic Markers —\u003c\/b\u003e Published trials have measured improvements in triglyceride profiles and adiponectin alongside VAT reduction, generating sustained interest in Tesamorelin as a tool for cardiometabolic-pathway research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCognitive Aging Research —\u003c\/b\u003e Randomized studies have explored Tesamorelin's effects on cognitive markers and brain GABA\/myo-inositol ratios in older adults, opening a parallel research direction beyond its primary metabolic indication.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with Tesamorelin often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-retatrutide-canada\" title=\"View Retatrutide Product Page\"\u003eRetatrutide\u003c\/a\u003e\u003c\/b\u003e — Triple GLP-1\/GIP\/glucagon agonist; provides a clean mechanistic contrast to GH-axis-driven body composition effects in metabolic-research designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-mots-c-canada\" title=\"View MOTS-c Product Page\"\u003eMOTS-c\u003c\/a\u003e\u003c\/b\u003e — Mitochondria-derived peptide investigated for insulin sensitivity and exercise-mimetic activity; complements Tesamorelin's endocrine angle with cellular-energetics research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-bpc-157\" title=\"View BPC-157 Product Page\"\u003eBPC-157\u003c\/a\u003e\u003c\/b\u003e — Pentadecapeptide studied for tissue repair and cytoprotection; pairs with Tesamorelin in research designs combining anabolic signaling and recovery endpoints.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eWhere can researchers buy Tesamorelin in Canada with verified purity?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eOur Tesamorelin ships to Canadian research labs and independent investigators with a batch-specific certificate of analysis confirming ≥99% HPLC purity and mass-spec identity verification. Vials are filled to approximately 104% of the labeled 10 mg as a quality margin for residual losses during reconstitution work, and ship from within Canada to avoid border-related cold-chain interruptions. Tesamorelin was originally developed in Canada by Theratechnologies, giving it a notable connection to Canadian peptide research.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow is Tesamorelin different from sermorelin or CJC-1295?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eSermorelin is a truncated GHRH(1-29) fragment with a much shorter half-life. CJC-1295 is also based on GHRH(1-29) but adds amino acid substitutions (and, in DAC variants, a maleimidopropionic acid linker for albumin binding). Tesamorelin retains the full GHRH(1-44) sequence with N-terminal lipid modification, giving it both DPP-IV resistance and the full receptor-binding domain of native GHRH — a different structural strategy from the truncated analogs.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIs Tesamorelin naturally occurring?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003ePartially. The 44-amino-acid sequence corresponds to native human GHRH, an endogenous hypothalamic peptide. The N-terminal trans-3-hexenoic acid modification is synthetic and does not occur in nature; it is added specifically to extend metabolic stability for research and clinical use.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhat is the evidence base for Tesamorelin?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eTesamorelin has the most developed evidence base of any GHRH analog. Phase 3 clinical trials in HIV-associated lipodystrophy supported its 2010 FDA approval, with published data on visceral fat reduction, IGF-1 elevation, lipid profiles, and tolerability. Subsequent research has examined cognitive aging, NAFLD, and broader metabolic endpoints.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️ \u003cem\u003eFor research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"10mg","offer_id":45745412472969,"sku":null,"price":84.99,"currency_code":"CAD","in_stock":true},{"title":"6x10mg","offer_id":45745412505737,"sku":null,"price":489.99,"currency_code":"CAD","in_stock":true},{"title":"10x10mg (one box)","offer_id":45745412538505,"sku":null,"price":749.99,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/tesamorelin-10mg-peptide-canada_standardized.png?v=1778370746","url":"https:\/\/emeraldpeptides.ca\/products\/buy-tesamorelin-canada","provider":"Emerald Peptides","version":"1.0","type":"link"}